Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

per Kitai, Hidenori, Ebi, Hiromichi
Publicat a Small GTPases (2016)

Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy

per Suimon, Yuka, Saito, Wataru, Hirooka, Kiriko, Kanda, Atsuhiro, Kitai, Hidenori, Sakakibara-Konishi, Jun, Ishida, Susumu
Publicat a Am J Ophthalmol Case Rep (2017)

Epithelial-to-mesenchymal transition defines feedback activation of receptor tyrosine kinase signaling induced by MEK inhibition in KRAS mutant lung cancer

per Kitai, Hidenori, Ebi, Hiromichi, Tomida, Shuta, Floros, Konstantinos V., Kotani, Hiroshi, Adachi, Yuta, Oizumi, Satoshi, Nishimura, Masaharu, Faber, Anthony C., Yano, Seiji
Publicat a Cancer Discov (2016)

Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration

per TANIMOTO, AZUSA, TAKEUCHI, SHINJI, YAEGASHI, HIROSHI, KOTANI, HIROSHI, KITAI, HIDENORI, NANJO, SHIGEKI, EBI, HIROMICHI, YAMASHITA, KANAME, MOURI, HISATSUGU, OHTSUBO, KOUSHIRO, IKEDA, HIROKO, YANO, SEIJI
Publicat a Mol Clin Oncol (2016)

Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM

per Song, Kyung-A, Niederst, Matthew J., Lochmann, Timothy L., Hata, Aaron N., Kitai, Hidenori, Ham, Jungoh, Floros, Konstantinos V., Hicks, Mark A., Hu, Haichuan, Mulvey, Hillary E., Drier, Yotam, Heisey, Daniel A.R., Hughes, Mark T., Patel, Neha U., Lockerman, Elizabeth L., Garcia, Angel, Gillepsie, Shawn, Archibald, Hannah L., Gomez-Caraballo, Maria, Nulton, Tara J., Windle, Brad E., Piotrowska, Zofia, Sahingur, Sinem E., Taylor, Shirley M., Dozmorov, Mikhail, Sequist, Lecia V., Bernstein, Bradley, Ebi, Hiromichi, Engelman, Jeffrey A., Faber, Anthony C.
Publicat a Clin Cancer Res (2017)